2. Results and Discussion
By a series of column chromatography in combination with HPLC, the acetone extract of
K. molle resulted in the purification of fifteen new diterpenoids, namely xishaklyanes A-O (
1-
15), along with three known related ones (
16-18) (
Figure 1). Those known diterpenoids were unambiguously identified as fuscol (
16) [
19], lobovarol H (
17) [
20], and 17,18-epoxyloba-8,10,13(15)-trien-16-ol (
18) [
21], respectively, by comparing their NMR data and specific rotation values with those reported in the literature.
Xishaklyane A (
1) was obtained as an optically active colorless oil. From the molecular ion peak at
m/z 289.2527 ([M + H]
+, calcd. 289.2526) in the HRESIMS spectrum, a molecular formula of C
20H
32O was established, indicating five degrees of unsaturation. The
1H and
13C NMR data of
1 (
Table 1 and
Table 3) highly resembled those of co-occurring
16, with the only differences of signals on C-4 (
δC 47.5 in
16 and 40.5 in
1), C-14 (
δC 15.3 in
16 and 20.2 in
1), and C-15 (
δC 122.9 in
16 and 124.6 in
1), suggesting that
1 was the analogue of
16, with the opposite geometry on
Δ13,15. Besides, the characteristic NOE correlation between H
3-14 and H-15 also confirmed the
Z geometry of
Δ13,15 in
1 (
Figure 2). The structure of
1 was further confirmed by 2D NMR analysis including HMBC and NOESY correlations. Thus, compound
1 was determined to be 13
Z-fuscol, namely xishaklyane A.
Xishaklyane B (
2) and xishaklyane C (
3) were initially isolated as a mixture [
22], displaying two sets of carbon signals in the
13C NMR spectrum. Normal Phase-High Performance Liquid Chromatography (NP-HPLC) CHIRALPAK
® IC (250 mm × 4.6 mm, 5 µm, Daicel Corporation, Japan) [n-hexane/isopropyl (99.7:0.3), 1.0 mL/min] (
2:
tR= 4.6 min;
3:
tR= 5.5 min) was used to successfully separate the mixture into
2 and
3. The absolute configurations (ACs) of
2 and
3 were further established by TDDFT-ECD calculations, a reliable approach to determine the ACs of natural products with chiral carbons near the chromophore groups [23-26]. As shown in
Figure 4, the Boltzmann-averaged ECD spectrum of (1
R,2
R,4
S,13
R,15
E)-
2 matched to the experimental ECD spectrum of
2, while the Boltzmann-averaged ECD spectrum of (1
R,2
R,4
S,13
S,15
E)-
3 matched to the experimental ECD spectrum of
3. Consequently, the ACs of
2 and
3 were determined to be 1
R, 2
R, 4
S, 13
R, 15
E, and 1
R, 2
R, 4
S, 13
S, 15
E, respectively. Thus, xishaklyanes B (
2) and C (
3) were deduced to be 13
R, 15
E-isofuscol and 13
S, 15
E-isofusol, respectively.
Xishaklyane D (
4) and xishaklyane E (
5) were also isolated as a pair of epimers which were separated by NP-HPLC [n-hexane/isopropyl (99.2:0.8), 1.0 mL/min] (
5:
tR= 6.5 min;
6:
tR= 5.6 min). The 1D and 2D NMR spectra of the mixture (
Table 1 and
Table 3) showed great similarity to those of the mixture of
2 and
3, with the only differences of the chemical shifts between C-13 and C-17, indicating the opposite geometry of
Δ15,16. The
Z geometry of
Δ15,16 was deduced by the
1H–
1H coupling constants (
J = 12.0 Hz). The ACs of
4 and
5 were also determined by TDDFT-ECD calculation. As shown in
Figure 4, the Boltzmann-averaged ECD spectrum of (1
R,2
R,4
S,13
R,15
Z)-
4 matched to the experimental ECD spectrum of
4, while the Boltzmann-averaged ECD spectrum of (1
R,2
R,4
S,13
S,15
Z)-
5 matched to the experimental ECD spectrum of
5. Consequently, the ACs of
4 and
5 were determined to be 1
R,2
R,4
S,13
R,15
Z. and 1
R,2
R,4
S,13
S,15
Z, respectively. Finally, xishaklyane D (
4) was determined as 13
R,15
Z-isofuscol, while xishaklyane E (
5) was determined to be 13
S,15
Z-isofusol.
Xishaklyane F (
6) was obtained as an optically active colorless oil. Its molecular formula was deduced to be C
22H
34O
3 on the basis of HRESIMS [sodiated ion peak at
m/z 369.2408 ([M + Na]
+, calcd. 369.2400)], indicating six degrees of unsaturation. The
1H and
13C NMR data of
6 were reminiscent of those of the known compound
17 (
Table 2 and
Table 3), with the only difference on C-14 (
δH 4.29, 4.31,
δC 60.0 in
17 and
δH 4.75, 4.75,
δC 61.6 in
6), as well as an additional acetyl group in
6 (
δH 2.07 s,
δC 21.2, 171.3), indicating the acetylation of 14-OH of
17 towards
6. To confirm our deduction, the acetylation of
17 (3 mg) was carried out using pyridine and Ac
2O at room temperature for 24 h. yielding the acetate
6 (2 mg). Thus, compound
6 was determined as the 14-acetate of the known compound lobovarol H (
17), namely xishaklyane F.
Xishaklyanes G and H (
7 and
8) were initially obtained as a mixture, which were further separated by NP-HPLC [n-hexane/isopropyl (90:10), 0.9 mL/min] (
7:
tR= 6.4 min;
8:
tR= 5.6 min). They showed the same molecular ion peak at
m/z 303.2329 ([M - H]
−, calcd. 303.2330) in the HRESIMS spectrum, and owned the same molecular formula of C
20H
32O
2, indicating compound
7 to be isomeric with
8. Detailed analysis of their NMR data suggested an epimeric relationship between
7 and
8. The
1H and
13C NMR data of
7 and
8 (
Table 2 and
Table 3) showed difference at C-15 and its neighboring carbons (e.g., C-3, C-5 and C-14), indicating
7 and
8 may have the opposite configuration of 15-OH. For the planar structure of both compounds, taking
7 for an example, its
1H and
13C NMR and HSQC resonances as well as coupling constants of the connected protons, indicated the presence of one monosubstituted terminal double bond [
δH 5.81 (dd,
J = 17.8, 10.5 Hz), 4.91 (d,
J = 17.8 Hz), 4.90 (d,
J = 10.5 Hz),
δC 110.1 (t),
δC 150.3 (s)], two disubstituted terminal olefinic bond [
δH 4.82 (s),
δH 4.58 (s),
δC 112.4 (t),
δC 147.7 (s);
δH 4.99 (s),
δH 5.15 (s),
δC 109.0 (t),
δC 156.0 (s)], and two monosubstituted double bond [
δH 5.66 (dd,
J = 15.6, 6.5 Hz),
δH 5.90 (d,
J = 15.6 Hz),
δC 128.2 (d),
δC 139.7 (d)]. The above olefinic bonds accounted for four degrees of unsaturation, so the remaining one degree should be ascribed to a ring in the molecule. Further analysis of
1H–
1H COSY spectrum of compound
7 revealed three structural fragments
a–c. These fragments were connected with well resolved HMBC correlations from H
3-7 to C-1/C-2/C-6/C-8, from H
3-12 to C-2/C-10/C-11, from H
3-19/H
3-20 to C-17/C-18, and from H
2-14 to C-4/C-13/C-15 (
Figure 2). Consequently, the planar structure of
7 was identified as shown in
Figure 1, featuring a lobane-type diterpenoid skeleton. The determination of the relative configurations (RCs) of
7 and
8 were highly challenging, because chiral carbon on side chain whose RCs cannot be elucidated by only a NOESY experiment. The
E geometry of
Δ16,17 was deduced by the
1H–
1H coupling constants (
J = 15.6 Hz). NOE correlations of H-4/H-3
β/H-2 revealed that these protons were disposed at the same side of the molecule, and randomly assigned as
β-oriented. Besides, the correlation of H
3-7/H-3
α revealed that these protons and proton-bearing groups were positioned at the other side of the molecule, thus
α-directed (
Figure 2). The ACs of
7 and
8 were determined by the TDDFT-ECD calculation. As shown in
Figure 5, the Boltzmann-averaged ECD spectrum of (1
R,2
R,4
S,15
R,16
E)-
7 matched to the experimental ECD spectrum of
7, while the Boltzmann-averaged ECD spectrum of (1
R,2
R,4
S,15
S,16
E)-
8 matched to the experimental ECD spectrum of
8. Consequently, the absolute configuration of
7 was determined to be 1
R,2
R,4
S,15
R,16
E. The absolute configuration of
8 was determined to be 1
R,2
R,4
S,15
S,16
E.
Xishaklyane I (
9) was obtained as an optically active colorless oil. Its molecular formula of C
20H
30O was determined from the molecular ion peak at
m/z 286.2288 ([M]
+, calcd. 286.2291) in the HREIMS spectrum, indicating six degrees of unsaturation. Under detailed diagnostic 2D NMR spectra, as well as coupling constants of the connected protons (
Table 2 and
Table 3), compound
9 own the same skeleton as the previously mentioned compounds. The major differences between them mainly happened at the C-14 position. An ether bridge between C-14 and C-16 formed a furan ring, which can further verificated by HMBC correlation from H-16 to C-14. As for the relative stereochemistry of
9, the relative configurations at C-1, C-2 and C-4 were suggested to be the same as that of
1-
8, which was supported by the similar NOE relationships observed in the NOESY spectrum (
Figure 2). Therefore, there are only two possibilities for the RC of
9 [(1
R*, 2
R*, 4
S*, 16
R*)-
9 and (1
R*, 2
R*, 4
S*, 16
S*)-
9]. Thus, the QM-NMR calculation and DP4+ analyses [27-29] of
13C NMR parameter on the two possible candidate diastereoisomers were performed. Finally, the experimentally observed
13C NMR data for
9 gave its best match for the 1
R*, 2
R*, 4
S*, 16
R* isomer (
9a, see the details in SI), with a 99.83% probability. Like the AC of fuscol, consequently, the absolute configuration of
9 was determined to be 1
R,2
R,4
S,13
Z,16
R.
The molecular formula C
20H
30O
2 of Xishaklyane J (
10) was deduced by the HRESIMS molecular ion peak at
m/z 303.2315, implying six degrees of unsaturation. The
1H and
13C NMR data of
10 (
Table 2 and
Table 3) was closely reminiscent of those of the co-occurrent 17,18-epoxyloba-8,10,13(15)-trien-16-ol (
18). The only difference between them was the presence of a terminal alkene (C-13/C-14) and an epoxide (C-15/C-16) in
10 instead of a trisubstituted double bond (C-13/C-15) and a hydroxyl (C-16) in
18. The detailed 2D NMR analysis shown in
Figure 2 confirmed its planar structure. To further confirm the structure and RC of
10, the QM-NMR calculation and DP4+ analyses were used. Finally, the experimentally observed NMR data for
10 gave its best match for the 1
R*, 2
R*, 4
S*, 16
S*, 17
R*, 18
R* isomer (
10d, see the details in SI), with a 100.00% probability. Like the AC of fuscol, consequently, the absolute configuration of
10 was determined to be 1
R,2
R,4
S,16
S,17
R,18
R.
Biogenetically, 10 was believed to be derived from compound 18 by an acid induced electron delivery from 16-OH to first generate the 15,16-epoxyl, and then promote the double bond migration towards the terminal olefin. The AC of the known compound 17,18-epoxyloba-8,10,13(15)-trien-16-ol (18) has not been defined. To obtain its absolute configuration at C-16, two aliquots of compound 18 were treated with (R)- and (S)-α-methoxy-α-trifluoromethylphenyl acetyl (MTPA) chlorides to obtain the (S)- and (R)-esters, respectively. Analysis of ΔδSR values (δS - δR) observed for the signals of the protons close to 16-OH indicated the R configuration at this carbon (Figure 6).
Xishaklyane K (
11) was obtained as an optically active colorless oil. Its molecular formula was deduced to be C
20H
32O on the basis of the HREIMS [molecular ion peak at
m/z 288.2443 ([M]
+, calcd. 288.2448)]. Careful analysis of the 1D NMR spectra of
11 (
Table 4 and
Table 5) showed a close similarity with those of co-occurring
16, indicating
11 also being a same side carbon chain at C-4. Further analysis of its 1D and 2D NMR spectra revealed that the main difference was between C-8 and C-12. The
1H–
1H COSY correlation of H
2-9/H
2-10 formed a six-membered ring, which can also deduce from the HMBC correlation from H
2-10 to C-8. Therefore, the planar structure was identified as shown in
Figure 1, a prenyleudesmane type diterpene. Now, the remaining task is to determine the structure and RC of
11. The
E geometry of
Δ16,17 was deduced by the
1H–
1H coupling constants (
J = 15.3 Hz) and the
E geometry of
Δ13,15 was deduced by the NOE correlations between H-15 and H-4 (
Figure 3). The relative configuration of chiral centers C-1, C-2 and C-4 in compound
11 was as the same as those compounds mentioned above. To determine the AC of
11, TDDFT-ECD calculation was performed. As shown in
Figure 5, the Boltzmann-averaged ECD spectrum of (1
S,2
R,4
S)-
11 matched to the experimental ECD spectrum of
11. Consequently, the AC of
11 was determined to be 1
S,2
R,4
S,13
E,16
E.
Xishaklyane L (
12) was obtained as an optically active colorless oil. From the molecular ion peak at
m/z 306.2553 ([M]
+, calcd. 306.2553) in the HREIMS spectrum, a molecular formula of C
20H
32O
2 was established. The structural features of
12 were reminiscent of the known compound lobovarol K [
20]. Compound
12 was methylated at the hydroxyl of C-18 to form lobovarol K. Besides, the same NOE correlations (
Figure 3) meant that the structure of
12 was tentatively determined to be the same as lobovarol K.
Xishaklyane M (
13) has a molecular formula C
20H
32O
3, as displayed from the ion peak in the HREIMS (
m/
z 320.2347 [M]
+). The 1D and 2D NMR data of
13 (
Table 4 and
Table 5) further revealed that it is a diterpene possessing the same double rings with identical substitutions as that of the eudesmane derivative. The NOE correlations between H
3-7 and H-3
α/H-5
α, H-3
α and H-5
α, H-8 and H-6
α, and between H-4 and H-6
β, suggested the
β-orientation of H-4, and the
α-orientation of H
3-7 and H-8, respectively (
Figure 3). The side chain was established by detailed 1D and 2D NMR data of
13, indicating a hydroxyl at C-16 and an epoxide at C-17/C-18, which is same to the known compound
18. Comparing their NMR data, the absolute configuration of
13 was tentatively determined to be 1
S,2
Z,4
S,8
R,13
E,16
R,17
R.
Xishaklyane N (
14) displayed a molecular formula of C
20H
32O
2 as established by the HREIMS ion peak at
m/z 304.2400 ([M]
+ calcd for 304.2397). The
1H and
13C NMR data of
14 (
Table 4 and
Table 5) were very similar with
11. Detailed analysis of those spectra of
14 and comparing with those of
11 recealed that the main differences between them happened at C-6 to C-8 segments. The HMBC correlations from H
3-7 to three carbons (C-1/C-5/C-6) insteated of four carbons (C-1/C-2/C-5/C-6) in
11, indicating a methyl was displaced at C-6. As for the stereochemistry of compound
14, the chemical shifts of C-14 (
δC 15.4, CH
3) and
J value of H-16 and H-17 (15.3 Hz) indicated the
E-geometry for the 13,15- and 16,17-double bonds, respectively. The NOE correlations between H
3-7 and H-1/H-2, H-1 and H-2, H-2 and H-3
β, and between H-4 and H-3
α, suggested the
β-orientation of H-1, H-2 and H
3-7, and the
α-orientation of H-4, respectively (
Figure 3). RC of
14: 1
S*, 2
S*, 4
S*, 6
R*. As shown in
Figure 5, the Boltzmann-averaged ECD spectrum of (1
S,2
S,4
S,6
R)-
14 matched to the experimental ECD spectrum of
14. Consequently, the AC of
14 was determined to be 1
S,2
S,4
S,6
R,13
E,16
E.
Xishaklyane O (
15) was also obtained as an optically active colorless oil. From the molecular ion peak at
m/z 304.2402 ([M]
+, calcd. 304.2397) in the HREIMS spectrum, a molecular formula of C
20H
32O
2 was established, indicating five degrees of unsaturation. Detailed analysis of 1D and 2D NMR spectra (
Table 4 and
Table 5) revealed that the same side chain as compounds
11,
12,
14 and
16. Further analysis of
1H–
1H COSY and HMBC spectrum of
15 revealed a 5/7-fused carbon ring system (
Figure 3). As for the stereochemistry of compound
15, the
E geometry of
Δ16,17 was deduced by the
1H–
1H coupling constants (
J = 15.3 Hz) and the
E geometry of
Δ13,15 was deduced by the chemical shifts of C-14 (
δC 14.9, CH
3). The NOE correlations between H-3
β and H-1/H-4, H-3
α and H-2, H-1 and H-4, and between H
3-12 and H-1, suggested the
α-orientation of H-1, H-2and H
3-12, and the
β-orientation of H-4, respectively. RC of
15: 1
S*, 2
R*, 4
S*, 11
R*. As shown in
Figure 5, the Boltzmann-averaged ECD spectrum of (1
S,2
R,4
S,11
R)-
15 matched to the experimental ECD spectrum of
15. Consequently, the absolute configuration of
15 was determined to be 1
S,2
R,4
S,11
R,13
E,16
E.
All compounds were screened for antibacterial activities on fish pathogenic bacteria. As shown in
Table 6, some of them exhibited considerable antibacterial activities. Among them, compound
5 was the most effective one with MIC of 0.225 μg/mL against
Lactococcus garvieae, whereas compound
11 showed the best antibacterial activity against
Streptococcus parauberis with MIC of 0.9 μg/mL.
3. Materials and Methods
3.1. General Experimental Procedures
Optical rotations were measured on a Perkin-Elmer 241MC polarimeter (PerkinElmer, Fremont, CA, USA). UV and CD spectra recorded on a Jasco J-815 spectropolarimeter (JASCO, Japan) at ambient temperature using chromatographic grade CH3OH and CH3CN as solvents. IR spectra were recorded on a Nicolet 6700 spectrometer (Thermo Scientific, Waltham, MA, USA); peaks are reported in cm-1. The NMR spectra were measured at 300K on Bruker Avance III 400, 500, 600 or 800 MHz NMR spectrometers (Bruker Biospin AG, Fällanden, Germany). Chemical shifts are reported in parts per million (δ) in CDCl3 (δH reported referred to CHCl3 at 7.26 ppm; δC reported referred to CDCl3 at 77.16 ppm) and coupling constants (J) in Hz; assignments were supported by 1H-1H COSY, HSQC, HMBC, and NOESY experiments. HREIMS data were recorded on a Finnigan-MAT-95 mass spectrometer (Finnigan-MAT, San Jose, CA, USA). HRESIMS spectra was recorded on an Agilent G6520 Q-TOF mass spectrometer (Agilent, Santa Clara, CA, USA). Semi-preparative RP-HPLC was performed on an Agilent-1260 system (Agilent, Santa Clara, CA, USA) equipped with a DAD G1315D detector at 210 and 254 nm using XDB-C18 column (250 mm × 9.4 mm, 5 µm) by eluting with CH3OH-H2O or CH3CN-H2O system at 3 mL/min. NP-HPLC was performed on a Shimadzu LC-6A system (Shimadzu, Japan) equipped with a DAD SPD-M20A detector using CHIRALPAK® IA or CHIRALPAK® IC (250 mm × 4.6 mm, 5 µm, Daicel Corporation, Japan) by eluting with n-hexane-isopropyl system at 1 mL/min. Commercial silica gel (100-200, 200-300 and 300-400 mesh; Qingdao Haiyang Chemical Group Co., Ltd., Qingdao, China) was used for column chromatography (CC). Precoated silica gel GF254 plates (Sinopharm Chemical Reagent Co., Shanghai, China) were used for analytical TLC. Spots were detected on TLC under UV light or by heating after spraying with anisaldehyde H2SO4 reagent. Sephadex LH-20 (Amersham Biosciences) was also used for CC. All solvents used for column chromatography and HPLC were of analytical grade (Shanghai Chemical Reagents Co., Ltd., Shanghai, China) and chromatographic grade (Dikma Technologies Inc., CA, USA), respectively.
3.2. Animal Material
Specimens of the soft coral Klyxum molle were collected by scuba diving at a depth of -20 m in Xisha Islands, Hainan Province, China, in 2019, and identified by Professor Xiu-Bao Li (Hainan University, Hainan, China). The biological material was frozen immediately after collection. A voucher specimen (19-XS-41) is available for inspection at Shanghai Institute of Materia Medica, Chinese Academy of Sciences.
3.3. Extraction and Isolation
The frozen animals (868 g, dry weight) of K. molle were cut into pieces and extracted exhaustively with acetone at room temperature (3 × 3.0 L). The organic extract was evaporated to give a brown residue, which was then partitioned between Et2O and H2O. The upper layer was concentrated under reduced pressure to give a brown residue (43.3 g), which was fractioned by gradient silica gel (200–300 mesh) column chromatography (CC) (0~100% Et2O in petroleum ether (PE)), yielding 11 fractions (A–K). Fr. D was fractioned by Sephadex LH-20 (PE/CH2Cl2/MeOH, 2:1:1) to obtain three sub-fractions Fr. Da, Db, and Dc. The subfraction Dc was separated on a column of silica gel (10~20% Et2O in PE) to afford 16 (1.31 g), 1 (0.26 g). Fr. C was fractioned by Sephadex LH-20 (PE/CH2Cl2/MeOH, 2:1:1) to obtain four sub-fractions Fr. Ca, Cb, Cc and Cd. The subfraction Cd was separated on a column of silica gel (5~20% Et2O in PE) to afford mixtures Cd2 and Cd6. Cd2 was further purified by RP-HPLC [MeOH/H2O (90:10), 3.0 mL/min] to give 10 (3.9 mg, tR = 11.0 min), Cd2c (0.7 mg, tR = 11.8 min). Cd6 was further purified by RP-HPLC [MeOH/H2O (95:5), 3.0 mL/min] to give 11 (1.1 mg, tR = 8.0 min), Cd6a (3.1 mg, tR = 5.3 min). Cd2c was purified by NP-HPLC [n-hexane/isopropyl (99.2:0.8), 1.0 mL/min] to give 4 (0.5 mg, tR = 6.5 min), 5 (0.2 mg, tR = 5.6 min). Cd6a was purified by NP-HPLC [n-hexane/isopropyl (99.7:0.3), 1.0 mL/min] to give 2 (1.4 mg, tR = 4.6 min), 3 (1.4 mg, tR = 5.5 min). Fr. G was fractioned by Sephadex LH-20 (PE/CH2Cl2/MeOH, 2:1:1) to obtain three sub-fractions Fr. Ga, Gb, and Gc. Gb was further purified by RP-HPLC [MeOH/H2O (85:15), 3.0 mL/min] to give 17 (0.9 mg, tR = 8.3 min), 18 (3.7 mg, tR = 13.7 min). Gc was further purified by RP-HPLC [MeCN/H2O (60:40), 3.0 mL/min] to give 9 (0.8 mg, tR = 10.4 min), 13 (0.6 mg, tR = 5.3 min). Fr. H was fractioned by Sephadex LH-20 (PE/CH2Cl2/MeOH, 2:1:1) to obtain three sub-fractions Fr. Ha, Hb, and Hc. The subfraction Hc was separated on a column of silica gel (50~75% Et2O in PE) to afford 6 (15.0 mg), and mixtures Hc1 and Hc2. Hc2 was further purified by RP-HPLC [MeCN/H2O (70:30), 3.0 mL/min] to give 14 (2.0 mg, tR = 9.3 min), Hc1 was further purified by RP-HPLC [MeCN/H2O (55:45), 2.0 mL/min] to give 12 (7.0 mg, tR = 21.3 min), 15 (1.0 mg, tR = 18.2 min), and Hc1d (1.3 mg, tR = 23.6 min). Hc1d was purified by NP-HPLC [n-hexane/isopropyl (90:10), 0.9 mL/min] to give 7 (0.5 mg, tR = 6.4 min), 8 (0.7 mg, tR = 5.6 min).
3.4. Spectroscopic Data of Compounds
Xishaklyane A (1): Colorless oil; [α –43.1 (c 1.95, CHCl3); UV (MeCN) λmax (log ε) 240 (3.31) nm; ECD (CH3CN) λmax (Δε) 215 (–5.2) nm; IR (KBr) νmax 3382, 2969, 2928, 2860, 1637, 1440, 1376, 1148,1005 cm-1; HRESIMS [M+H]+ m/z 289.2527 (calcd. for 289.2526, C20H33O).
Xishaklyane B (2): Colorless oil; [α –7.4 (c 0.14, CHCl3); UV (MeCN) λmax (log ε) 238 (3.23) nm; ECD (CH3CN) λmax (Δε) 201 (–1.6) nm.
Xishaklyane C (3): Colorless oil; [α +30.2 (c 0.14, CHCl3); UV (MeCN) λmax (log ε) 238 (3.27) nm; ECD (CH3CN) λmax (Δε) 232 (+2.3) nm.
Xishaklyane D (4) and Xishaklyane E (5): For 4, Colorless oil; [α –35.0 (c 0.05, CHCl3); UV (MeCN) λmax (log ε) 240 (3.29) nm; ECD (CH3CN) λmax (Δε) 240 (–3.4) nm; For 5, Colorless oil; [α +75.8 (c 0.02, CHCl3); UV (MeCN) λmax (log ε) 240 (3.35) nm; ECD (CH3CN) λmax (Δε) 244 (+3.8) nm; For mixture of 4 and 5, IR (KBr) νmax 3455, 2966, 2925, 2854, 1438, 1376, 1180, 1142, 1099, 1075,1029 cm-1; HREIMS [M]+ m/z 288.2454 (calcd. for 288.2448, C20H32O).
Xishaklyane F (6): Colorless oil; [α +33.5 (c 0.09, CHCl3); UV (MeCN) λmax (log ε) 239 (3.30) nm; ECD (CH3CN) λmax (Δε) 234 (+2.9) nm; IR (KBr) νmax 3451, 2968, 2925, 2854, 1735, 1377, 1260, 1230, 1075,1027 cm-1; HRESIMS [M + Na]+ m/z 369.2408 (calcd. for 369.2400, C22H34NaO3).
Xishaklyane G (7) and Xishaklyane H (8): For 7, Colorless oil; [α +25.3 (c 0.05, CHCl3); ECD (CH3CN) λmax (Δε) 196 (–4.4) nm; For 8, White solid; [α +24.0 (c 0.07, CHCl3); ECD (CH3CN) λmax (Δε) 204 (+5.6) nm; For mixture of 7 and 8, IR (KBr) νmax 3443, 2968, 2924, 2853, 1384, 1180, 1143, 1095, 1076, 1029 cm-1; HRESIMS [M - H]- m/z 303.2329 (calcd. for 303.2330, C20H31O2).
Xishaklyane I (9): Colorless oil; [α +67.9 (c 0.08, CHCl3); IR (KBr) νmax 3451, 2967, 2925, 2854, 1444, 1374, 1180, 1059, 1029 cm-1; HREIMS [M]+ m/z 286.2288 (calcd. for 286.2291, C20H30O).
Xishaklyane J (10): Colorless oil; [α +2.8 (c 0.09, CHCl3); IR (KBr) νmax 3454, 2965, 2926, 2856, 1643, 1456,1379, 1075, 1029 cm-1; HRESIMS [M + H]+ m/z 303.2315 (calcd. for 303.2319, C20H31O2).
Xishaklyane K (11): Colorless oil; [α -20.0 (c 0.11, CHCl3); UV (MeCN) λmax (log ε) 240 (3.34) nm; ECD (CH3CN) λmax (Δε) 200 (+2.0) nm; IR (KBr) νmax 3451, 2869, 2925, 2852, 1442, 1386, 1180, 1143, 1075, 1030 cm-1; HREIMS [M]+ m/z 288.2443 (calcd. for 288.2448, C20H32O).
Xishaklyane L (12): Colorless oil; [α +25.7 (c 0.70, CHCl3); UV (MeCN) λmax (log ε) 240 (3.33) nm; ECD (CH3CN) λmax (Δε) 242 (+2.1) nm; IR (KBr) νmax 3385, 2970, 2926, 2864, 1456, 1384, 1143, 1105 cm-1; HREIMS [M]+ m/z 306.2553 (calcd. for 306.2553, C20H34O2).
Xishaklyane M (13): Colorless oil; [α –13.3 (c 0.06, CHCl3); IR (KBr) νmax 3450, 2963, 2925, 2854, 1436, 1378, 1180, 1075, 1028 cm-1; HREIMS [M]+ m/z 320.2347 (calcd. for 320.2346, C20H32O3).
Xishaklyane N (14): Colorless oil; [α –15.5 (c 0.20, CHCl3); UV (MeCN) λmax (log ε) 239 (3.34) nm; ECD (CH3CN) λmax (Δε) 210 (–1.9) nm; IR (KBr) νmax 3450, 2963, 2925, 2857, 1386, 1180, 1143, 1095, 1075, 1028 cm-1; HREIMS [M]+ m/z 304.2400 (calcd. for 304.2397, C20H32O2).
Xishaklyane O (15): Colorless oil; [α –16.8 (c 0.10, CHCl3); UV (MeCN) λmax (log ε) 240 (3.38) nm; ECD (CH3CN) λmax (Δε) 197 (+4.2) nm; IR (KBr) νmax 3450, 2959, 2923, 2852, 1384, 1180, 1143, 1129, 1099, 1075, 1029 cm-1; HREIMS [M]+ m/z 304.2402 (calcd. for 304.2397, C20H32O2).
3.5. Esterification of 3 and 5 with MTPA chlorides
Compound 18 (2.0 mg) was dissolved in dry pyridine (1000 μL), and the solution was transferred into two NMR tubes (500 μL each), treated with (R)-(-)-2-methoxy-2-(trifluoromethyl) phenylacetyl chloride ((R)-(-)-MTPA-Cl) (20 μL) and (S)-(+)-2-methoxy-2-(trifluoromethyl) phenylacetyl chloride ((S)-(+)-MTPA-Cl) (20 μL), respectively. Carefully shaking and then monitored immediately by 1H NMR. The reaction was found to be completed in 30 min. Then the solutions were evaporated in vacuo and the residue was purified by silica gel CC (10% Et2O in PE) to obtain the S-MTPA ester 18s, and R-MTPA ester 18r, respectively. For (S)-MTPA ester of 18 (18s), Selected 1H NMR (CDCl3, 400 MHz): δH 5.812 (1H, dd, J = 17.6, 10.7 Hz, H-8), 5.626 (1H, t, J = 9.2 Hz, H-16), 5.359 (1H, d, J = 9.8 Hz, H-15), 4.917 (1H, d, J = 15.9 Hz, H-9α), 4.912 (1H, d, J = 12.4 Hz, H-9β), 4.842 (1H, s, H-11α), 4.585 (1H, s, H-11β), 2.997 (1H, d, J = 8.4 Hz, H-17), 2.009 (1H, d, J = 12.2 Hz, H-4), 1.827 (3H, s, Me-14), 1.713 (3H, s, Me-12), 1.338 (3H, s, Me-20), 1.323 (3H, s, Me-19), 1.013 (3H, s, Me-7). For (R)-MTPA ester of 18 (18r), Selected 1H NMR (CDCl3, 400 MHz): δH 5.807 (1H, dd, J = 17.6, 10.6 Hz, H-8), 5.591 (1H, t, J = 9.2 Hz, H-16), 5.148 (1H, d, J = 10.1 Hz, H-15), 4.911 (1H, d, J = 16.6 Hz, H-9α), 4.910 (1H, d, J = 11.5 Hz, H-9β), 4.848 (1H, s, H-11α), 4.579 (1H, s, H-11β), 2.996 (1H, d, J = 8.6 Hz, H-17), 1.995 (1H, d, J = 11.9 Hz, H-4), 1.856 (3H, s, Me-14), 1.713 (3H, s, Me-12), 1.358 (3H, s, Me-20), 1.331 (3H, s, Me-19), 0.997 (3H, s, Me-7).
3.6. QM-NMR Calculational Section
For the QM-NMR calculations of compounds, torsional sampling (MCMM) conformational searches using OPLS_2005 force field were carried out by the means of conformational search module in Macro model 9.9.223 software (Schrodinger,
http://www.schrodinger. com/MacroModel), applying an energy window of 21 kJ/mol (5.02 kcal/mol) for saving structures. The following DFT calculations were performed using Gaussian 09, and Conformers above 1% population were reoptimized at B3LYP/6-311G(d,p) level of theory. Magnetic shielding constants (σ) were calculated by means of the gauge including atomic orbitals (GIAO) method at mPW1PW91/6-31+G(d,p) level of theory as recommended for DP4+ analysis.
3.7. TDDFT-ECD Calculational Section
For the time-dependent density functional theory/electronic circular dichroism (TDDFT-ECD) calculations of compounds, conformational searches were done following the general protocols previously described for QM-NMR calculation. Conformers above 1% population were used for re-optimizations and the following TDDFT-ECD calculations, which were performed using Gaussian 09 at the B3LYP/6-311G(d,p) level of theory with IEFPCM solvent model for acetonitrile. Finally, the SpecDis 1.62 software was used to obtain the calculated ECD spectrum and visualize the results.
3.8. Antibacterial assays
Five pathogenic bacteria, namely Streptococcus parauberis KSP28, Streptococcus parauberis SPOF3K, Lactococcus garvieae MP5245, Aeromonas salmonicida AS42, and Photobacterium damselae FP2244, were provided by National Fisheries Research & Development Institute, Korea. MIC values of test compounds were determined by the modified 0.5 Mcfarland standard method.